Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Leibowitch

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
La Revue Du Praticien|March 1, 1980
[Complement in human disease: hypocomplementemias]J Leibowitch
La Revue Du Praticien|March 11, 1980
[Immunologic purification]J Leibowitch
La Nouvelle Presse Medicale|June 30, 1979
[Progress in the knowledge of complement. I. Structure, activation and control of the complement system]P Lesavre, J Leibowitch
La Nouvelle Presse Medicale|July 7, 1979
[Progress in the knowledge of complement. II. Nephritic factors]J Leibowitch, P Lesavre
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|February 5, 1979
[Description of an unusual enzymic activity cleaving the third component of complement]J Leibowitch, M Leveille, L Halbwachs
Nouvelle Revue Francaise D'Hematologie|January 1, 1981
[Mixed nodular lymphoma in association with a C1 esterase inhibitor deficiency (author's transl)]M Leporrier, M Raphaël, A Delcourt, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1980
Glomerulonephritides and hypocomplementemia: pathophysiology and pathogenic implicationsJ Leibowitch, M Leveille, L Halwachs, et al.
The Journal of Experimental Medicine|July 1, 1981
Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertaseI Gigli, J Sorvillo, L Mecarelli-Halbwachs, et al.
Clinical and Experimental Immunology|November 1, 1980
In vitro characteristics on human lymphocyte functions of a new immunomodulatory agent, a cyclic peptide, cyclomunineP Niaudet, G Beaurain, J Leibowitch, et al.
British Medical Journal (Clinical Research Ed.)|February 28, 1981
Systemic lambda light-chain deposition in a patient with myelomaD Ganeval, L H Noël, D Droz, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
La Revue Du Praticien|March 1, 1980
[Complement in human disease: hypocomplementemias]J Leibowitch
La Revue Du Praticien|March 11, 1980
[Immunologic purification]J Leibowitch
La Nouvelle Presse Medicale|June 30, 1979
[Progress in the knowledge of complement. I. Structure, activation and control of the complement system]P Lesavre, J Leibowitch
La Nouvelle Presse Medicale|July 7, 1979
[Progress in the knowledge of complement. II. Nephritic factors]J Leibowitch, P Lesavre
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|February 5, 1979
[Description of an unusual enzymic activity cleaving the third component of complement]J Leibowitch, M Leveille, L Halbwachs
Nouvelle Revue Francaise D'Hematologie|January 1, 1981
[Mixed nodular lymphoma in association with a C1 esterase inhibitor deficiency (author's transl)]M Leporrier, M Raphaël, A Delcourt, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1980
Glomerulonephritides and hypocomplementemia: pathophysiology and pathogenic implicationsJ Leibowitch, M Leveille, L Halwachs, et al.
The Journal of Experimental Medicine|July 1, 1981
Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertaseI Gigli, J Sorvillo, L Mecarelli-Halbwachs, et al.
Clinical and Experimental Immunology|November 1, 1980
In vitro characteristics on human lymphocyte functions of a new immunomodulatory agent, a cyclic peptide, cyclomunineP Niaudet, G Beaurain, J Leibowitch, et al.
British Medical Journal (Clinical Research Ed.)|February 28, 1981
Systemic lambda light-chain deposition in a patient with myelomaD Ganeval, L H Noël, D Droz, et al.
Pageof 6